Fortis Healthcare Limited
FORTIS · Hospitals · NSE
₹868
Current Market Price
Fair Value (DCF)
₹438
Margin of Safety
-49.5%
Updated just now
YieldIQ Score
43/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
42%
ROE
8.4%
Debt/Equity
0.00
WACC
10.8%
Market Cap
₹0.65 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
9.6%
Return on capital employed
EV / EBITDA
35.6×
Enterprise multiple
Debt / EBITDA
1.6×
Leverage vs earnings
Interest Coverage
7.5×
EBIT covers interest
Current Ratio
0.92×
Short-term liquidity
Asset Turnover
0.58×
Revenue per ₹ of assets
Revenue CAGR (3Y)
11.9%
3-year revenue growth
Revenue CAGR (5Y)
16.7%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹867.55
Bear case
₹263.79
MoS -228.9%
Base case
₹437.98
MoS -98.1%
Bull case
₹582.15
MoS -49.0%
Ratio Trends
FORTIS · last 8 annual periods
ROE
8.4%
ROCE
13.3%
Operating Margin
—
Debt / Equity
0.27×
PE
9478.9×
EV / EBITDA
16.0×
Historical Financials
FORTIS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹4030 Cr | ₹5718 Cr | ₹6213 Cr | ₹6835 Cr | ₹7724 Cr | +17.7% |
| EBITDA | — | ₹1416 Cr | ₹1238 Cr | ₹1309 Cr | ₹1547 Cr | +2.2% |
| EBIT | ₹258 Cr | ₹1110 Cr | ₹28.2 Cr | ₹302 Cr | — | +4.0% |
| PAT | ₹62.4 Cr | ₹790 Cr | ₹589 Cr | ₹599 Cr | ₹774 Cr | +87.7% |
| EPS (diluted) | ₹-1.45 | ₹7.35 | ₹0.03 | ₹2.37 | — | — |
| CFO | ₹486 Cr | ₹865 Cr | ₹822 Cr | ₹1100 Cr | ₹1424 Cr | +30.9% |
| CapEx | — | — | — | — | ₹-847 Cr | — |
| FCF | — | — | — | — | ₹577 Cr | +0.0% |
| Total Assets | — | ₹11.9K Cr | ₹10.4K Cr | ₹13.3K Cr | ₹13.7K Cr | +3.6% |
| Total Debt | — | — | ₹160 Cr | ₹117 Cr | ₹2475 Cr | +98.4% |
| Shareholders' Equity | — | — | ₹8964 Cr | ₹7663 Cr | ₹9169 Cr | +0.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
FORTIS vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| MAXHEALTH MAXHEALTH | — | — | Pending | 11.5% | — |
| APOLLOHOSP APOLLOHOSP | — | — | Pending | 16.7% | 65.8× |
| NH NH | — | — | Pending | 21.8% | — |
| ASTERDM ASTERDM | — | — | Pending | 147.3% | — |
| MEDANTA MEDANTA | — | — | Pending | 14.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
3 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹3.00/sh
Last payout
2025-07-25
₹1.00
Peak payout
₹1.00
Trailing yield
0.12%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Fortis Healthcare Limited (FORTIS.NS) trades at 867.55 vs a model fair value of 437.98, a gap of -49.5%. Piotroski F-score: 6/9. Moat lab...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of FORTIS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for FORTIS →
Compare
Head-to-head with peers
Compare FORTIS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse FORTISNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.